Table 2 |
|||||
|
Funding source by trial outcome |
|||||
|
Funding Source |
|||||
|
|
|||||
|
Direction and Statistical Significance of Trial Outcome |
Industry ONLY |
Not for Profit ONLY |
Mixed + |
Not Reported |
TOTAL |
|
|
|||||
|
Favoured New |
30 |
15 |
16 |
6 |
67 |
|
Favoured Conventional |
4 |
1 |
1 |
0 |
6 |
|
Neutral |
6 |
9 |
4 |
0 |
19 |
|
Unclear |
4 |
3 |
1 |
0 |
8 |
|
Total |
44 |
28 |
22 |
6 |
100 |
|
|
|||||
|
p = .461 |
|||||
|
|
|||||
|
+ = funding by at least one industry source and at least one not-for-profit source |
|||||
|
Clifford et al. BMC Health Services Research 2002 2:18 doi:10.1186/1472-6963-2-18 |
|||||